NVASC
NVasc is an early-stage ophthalmology company with a focus on treating blindness. It specializes in treating the leading causes of blindness through choroidal and retinal revascularization. The company has acquired the research rights to growth factors (NVB001 and NVB002) that have been shown to encourage the growth of non-leaking new vessels in the retina and choroid in mouse models of ischemic eye diseases. The company is planning to manufacture NVB001 which can be used in toxicokinetic studies and in early clinical trials in humans.
NVASC
Industry:
Health Care Medical Device Therapeutics
Founded:
2019-01-01
Address:
Atherton, California, United States
Country:
United States
Status:
Active
Total Funding:
0
Similar Organizations
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Current Employees Featured
Founder
Investors List
Kairos Ventures
Kairos Ventures investment in Venture Round - NVasc